|
Volumn 17, Issue 8, 1998, Pages 809-816
|
Outpatient inotropic therapy in heart transplant candidates: Should its use influence waiting list priority status?
a
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMRINONE;
BETA ADRENERGIC RECEPTOR STIMULATING AGENT;
DIGOXIN;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
DOBUTAMINE;
HYDRALAZINE;
INOTROPIC AGENT;
ISOSORBIDE DINITRATE;
PHOSPHODIESTERASE INHIBITOR;
VASODILATOR AGENT;
ADULT;
ARTICLE;
CONTROLLED STUDY;
DETERIORATION;
HEART FAILURE;
HEART TRANSPLANTATION;
HOSPITAL ADMISSION;
HOSPITALIZATION;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
MAJOR CLINICAL STUDY;
MORBIDITY;
MORTALITY;
ORAL DRUG ADMINISTRATION;
OUTPATIENT CARE;
PATIENT SELECTION;
PRIORITY JOURNAL;
SURVIVAL RATE;
TREATMENT OUTCOME;
ADMINISTRATION, ORAL;
ADULT;
CARDIOTONIC AGENTS;
FEMALE;
HEART DISEASES;
HEART TRANSPLANTATION;
HUMANS;
INJECTIONS, INTRAVENOUS;
MALE;
MIDDLE AGED;
OUTPATIENTS;
RETROSPECTIVE STUDIES;
SURVIVAL RATE;
TREATMENT OUTCOME;
WAITING LISTS;
|
EID: 0031702665
PISSN: 10532498
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (10)
|
References (10)
|